United Kingdom· GB-APID-45789311000001105
Nulibry 9.5mg powder for solution for injection vials
A fosdenopterin product containing fosdenopterin, registered in United Kingdom by Sentynl Therapeutics, Inc.. The same ATC class is registered in 11 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Fosdenopterin is registered in 11 of 19 countries.
Countries holding a registration under ATC A16AX19 (fosdenopterin), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 7 of them publish a price we can compare per daily dose
Fosdenopterin · ATC A16AX19
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Fosdenopterin
- Manufacturer
- Sentynl Therapeutics, Inc.
- Country
- United Kingdom (GB)
- ATC code
- A16AX19
- ATC class
- Fosdenopterin
- Defined daily dose
- 63 mg, P
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin05391543420444
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Fosdenopterin in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumNulibry 9.5 mgTMC Pharma (EU)
- CzechiaNULIBRYTMC Pharma (EU) Limited, Waterford
- IcelandNulibryTMC Pharma (EU) Limited
- NorwayNulibryTmc Pharma (EU) Limited
- PolandNULIBRYTMC Pharma (EU) Ltd.
- SwedenNULIBRY 9,5 mg Pulver till injektionsvätska, lösningTMC Pharma (EU) Limited
- United StatesNulibrySentynl Therapeutics, Inc.
- FinlandNULIBRYTMC Pharma (EU) Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Nulibry
- Liechtenstein · Nulibry
- Norway · Nulibry
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/970ce408-6e0a-4161-b78c-74f3361209ae GET /v1/drugs/970ce408-6e0a-4161-b78c-74f3361209ae?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "45789311000001105",
"desc": "Nulibry 9.5mg powder for solution for injection vials (Sentynl Therapeutics, Inc.)",
"form": "Powder for solution for injection",
"vpid": "45792011000001104",
"source": "dmd",
"vtm_id": "1153618003",
"strength": "9.5 mg",
"substance": "Fosdenopterin",
"ingredient": "Fosdenopterin hydrobromide dihydrate",
"supplier_code": "41824011000001103"
}See everything about fosdenopterin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.